By
AmyT on
March 12, 2009
I see that we need a little clarification here: we’ve been getting some queries from folks with great diabetes design ideas, who are a bit hesitant to enter the 2009 DiabetesMine Design Challenge contest for fear of giving up the rights to their intellectual property. No worries! Here’s what you need to know:
You (the contest participant) retain the full IP rights to your idea. We (the contest organizers) don’t take ownership of anything. The…
Read more »
By
AmyT on
March 12, 2009
A physician-friend of mine is raving about The Innovator’s Prescription by Clay Christensen and team. My friend tells me it’s the best book ever written on health care, and has even sent me a copy via Amazon.com as an early birthday present (thank you!)
Indeed, the author himself claims it’s “the first book ever that actually presents a plausible roadmap to make health care affordable in this country,” and the New York Times seems to…
Read more »
As you all know, President Obama lifted Bush’s longstanding restrictions on federal funding of human embryonic stem cell research yesterday — a huge breakthrough for all those who believe this avenue could produce unprecedented treatments for many incurable diseases. Like diabetes.
Among others, the Juvenile Diabetes Research Foundation (JDRF) has fought long and hard for this boost. Its staff and members are pretty much ecstatic. A small group including Larry Soler, the organization’s EVP of…
Read more »
This week’s Diabetes Forum 2009 conference was two full days of presentations on policy and reform — a dizzying array of statistics and political jargon and acronyms like “four-tier formularies,” “SNPs” and “VBID” and “double-digit Medicare margin.” Surely all very important stuff in the netherworlds of managed care and reimbursement administration. But what the heck?! I gladly reminded this crowd that these terms mean little if nothing to the average patient.
So what DOES concern…
Read more »
I’m sorry to report that the first day of the two-day Diabetes Forum 2009 conference here in snowy Washington, DC, was not very encouraging. Don’t get me wrong, the event was extremely well-organized, well-attended, and fascinating. It’s just that what we were hearing was a lot of bad news about the state of diabetes care in this country and the gargantuan task ahead of policymakers in reforming our healthcare system. Not much new there.
However,…
Read more »
